Drug General Information
Drug ID	D0N5UA
Former ID	DPR000037
Drug Name	Dianicline+rimonabant
Drug Type	Small molecular drug
Indication	Tobacco dependence [ICD9: 305.1; ICD10:F17]		Terminated	[548622]
Company	Sanofi-Aventis
Structure		Download 2D MOL 3D MOL
Formula	C21H26ClN3O2
PubChem Compound ID	156333
Target and Pathway
Target(s)	Nicotinic acetylcholine receptor	Target Info	Agonist	[537145]
	Cannabinoid receptor 1	Target Info	Agonist	[537145]
KEGG Pathway	Rap1 signaling pathway
	Neuroactive ligand-receptor interaction
	Retrograde endocannabinoid signaling
PANTHER Pathway	Endogenous cannabinoid signaling
Pathway Interaction Database	N-cadherin signaling events
Reactome	Class A/1 (Rhodopsin-like receptors)
	G alpha (i) signalling events
WikiPathways	GPCRs, Class A Rhodopsin-like
	Small Ligand GPCRs
	BDNF signaling pathway
	GPCR ligand binding
	GPCR downstream signaling
	GPCRs, Other
References
Ref 548622	Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800027143)
Ref 537145	Emerging drugs for the treatment of tobacco dependence. Expert Opin Emerg Drugs. 2009 Mar;14(1):23-32.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.